前收市價 | 1.5000 |
開市 | 1.5000 |
買盤 | 0.0500 |
賣出價 | 0.0000 |
拍板 | 5.00 |
到期日 | 2024-10-18 |
今日波幅 | 1.5000 - 1.5000 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 13 |
Werewolf Therapeutics (HOWL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
The consensus price target hints at a 92.4% upside potential for Werewolf Therapeutics, Inc. (HOWL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Werewolf Therapeutics, Inc. (HOWL) delivered earnings and revenue surprises of 23.26% and 45.42%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?